Le Lézard
Classified in: Health
Subject: PDT

Dr. Philip Fan J.P. (?????) Launches Comprehensive Dental Clinic in Shenzhen to Meet Changing Consumer Needs of Hong Kongers


HONG KONG, May 21, 2024 /PRNewswire/ -- The lifting of pandemic travel restrictions has driven a surge of Hong Kongers visiting mainland China for consumption, with dental services becoming a popular spending category. The dental clinic opened in Shenzhen by Dr. Philip Fan, J.P. (?????), the former Chairman of the Board of Directors, Tung Wah Group of Hospitals and the founder of Beame (???), has seen tremendous popularity with Hong Kong customers, at one point serving nearly 1,000 per day.

Dr. Philip Fan J.P. (?????) aims to provide more Hong Kongers access to comprehensive, cost-effective dental care, while also leveraging the Shenzhen clinic to help address Hong Kong's dental services supply-demand imbalance.

Dr. Philip Fan (?????): Shenzhen Costs Allow Affordable Dental Care for Hong Kongers

Located near Lo Wu station, the 100,000 square feet Beame (???) clinic houses around 100 dentists providing professional services. Founder Dr. Philip Fan J.P. (?????) understands that Hong Kong consumers now prioritize quality and value over just lower prices when traveling to the mainland. Beame is purposefully designed with an upscale clubhouse ambiance, unlike typical dental clinics. Additionally, Beame delivers premium customer service, with attentive Cantonese-speaking staff creating a welcoming environment for patients.

Shenzhen's lower labor and rental costs enable Beame to charge just one-third the fees of local Hong Kong practitioners. Dr. Philip Fan J.P. (?????) believes Hong Kong patients can benefit from these cost advantages and reduced wait times.

Beame also offers complimentary CT scans to help patients understand their issues and receive tailored treatment quotes. Prices for services like cleanings, fillings, and root canals are more affordable, allowing Hong Kong customers to access comprehensive and value-for-money dental care.

Dr. Philip Fan (?????) Eases Hong Kongers' Concerns Over Mainland Dental Services

Beame (???) in Shenzhen offers dental services comparable to Hong Kong's Central clinics, but at more affordable prices for Hong Kongers. According to Dr. Philip Fan J.P. (?????), while some initially had reservations about mainland dental care, Beame has built a large customer base through positive word-of-mouth. Moving forward, the clinic will continue providing high-quality services at preferential prices, giving Hong Kongers better dental options and helping address supply-demand imbalances.

Dr. Philip Fan J.P. (?????) emphasized his goal is to provide excellent, affordable dental care for Hong Kongers. He plans to expand Beame's Shenzhen clinics to meet growing demand. Beame is also actively expanding overseas, aiming to become a leading international dental brand.

This press release is sent by BEAME Medical Technology Limited. For enquiry, please contact:
Jane Ng
Mobile +852 5286 0518
Email: [email protected]

SOURCE Beame


These press releases may also interest you

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...



News published on and distributed by: